QL2108 injection
QL2108-101
Phase 1 small_molecule completed
Quick answer
QL2108 injection for Atopic Dermatitis is a Phase 1 program (small_molecule) at Qilu Pharmaceutical (Hainan) Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Qilu Pharmaceutical (Hainan) Co.,
- Indication
- Atopic Dermatitis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed